KR20120086436A - Cosmetic composition for slimming - Google Patents
Cosmetic composition for slimming Download PDFInfo
- Publication number
- KR20120086436A KR20120086436A KR1020110007653A KR20110007653A KR20120086436A KR 20120086436 A KR20120086436 A KR 20120086436A KR 1020110007653 A KR1020110007653 A KR 1020110007653A KR 20110007653 A KR20110007653 A KR 20110007653A KR 20120086436 A KR20120086436 A KR 20120086436A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- extract
- quinoa
- safflower
- green tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 녹차(Camellia sinensis L.)씨, 블래더랙(Fucus vesiculosus L.), 차전초(Plantago asiatica L), 홍화(Carthamus tinctorius L.) 및 퀴노아(Chenopodium quinoa Willd.)를 포함하는 화장료 조성물에 관한 것으로서, 상기 화장료 조성물은 지방세포 내 중성지방(triglyceride) 생성을 억제시킴으로써 우수한 슬리밍 효과를 나타낸다.The present invention is a green tea ( Camellia sinensis L.) seeds, bladder rack ( Fucus vesiculosus L.), Plantago asiatica L), safflower ( Carthamus tinctorius L.) and quinoa ( Chenopodium quinoa Willd.) Relates to a cosmetic composition, the cosmetic composition exhibits an excellent slimming effect by inhibiting triglyceride production in adipocytes.
Description
본 발명은 녹차(Camellia sinensis L.)씨, 블래더랙(Fucus vesiculosus L.), 차전초(Plantago asiatica L), 홍화(Carthamus tinctorius L.) 및 퀴노아(Chenopodium quinoa Willd.)를 포함하는 화장료 조성물에 관한 것으로서, 상기 화장료 조성물은 지방세포 내 중성지방(triglyceride) 생성을 억제시켜 우수한 슬리밍 효과를 나타낸다.
The present invention is a green tea ( Camellia sinensis L.) seeds, bladder rack ( Fucus vesiculosus L.), Plantago asiatica L), safflower ( Carthamus tinctorius L.) and Quinoa ( Chenopodium quinoa Willd.) Relates to a cosmetic composition, the cosmetic composition exhibits an excellent slimming effect by inhibiting triglyceride production in adipocytes.
생활이 윤택해짐에 따라 피부미용이나 건강에 관한 관심이 증대되고 있다. 이중 비만은 많은 문제를 야기하고 있다. 비만이란 일반적으로 피부층 아래에 있는 피하지방조직의 이상 비대화를 말한다. 특히 얼굴, 팔, 허벅지 혹은 둔부나 복부 등에서 나타나는 국소비만은 특정 부위에 지방이 축적되는 상태로 이는 전신적 대사 불균형에 의한 비만과는 다른 문제로 특히 여성들의 경우 에스트로겐 (estrogen)의 영향으로 α2-아드레날린 수용체 (α2-adrenaline receptor)가 둔부(hip)와 허벅지(thigh)의 지방세포에 더 많이 분포하여 발생한다. As life improves, interest in skin care and health is increasing. Obesity is causing a lot of problems. Obesity is usually an abnormal enlargement of subcutaneous fat tissue under the skin layer. Local obesity, especially on the face, arms, thighs, buttocks and abdomen, is a condition in which fat accumulates in a specific area, which is different from obesity caused by systemic metabolic imbalances. It is caused by the greater distribution of receptors (α2-adrenaline receptors) in fat cells in the hips and thighs.
한편, 지방조직은 해부학적 위치, 형태학적 구조, 기능 및 조절에 따라 백색지방(white adipose tissue, WAT)과 갈색지방(brown adipose tissue, BAT)으로 구별된다. 지방세포의 분화과정은 일생을 통해 지방전구세포에서 지방세포로 지속적으로 전환되는데, 지방전구세포로부터 지방세포로의 분화는 뚜렷이 형태학적으로 그리고 생화학적인 변화를 보인다. 3T3-L1 세포처럼 이미 확립된 지방전구세포나 지방조직 유래의 기질전구세포는 in vitro에서 지방세포생성의 과정을 관찰하는데 널리 사용되어왔다. 지방세포의 분화는 지방세포 유도복합체의 조합에 의해 유도된다. 이 지방세포생성복합체의 처리에 의해서 세포는 형태가 변하기 시작하고 얼마간의 세포분열이 동행되며 5-7일간에 지방세포의 표현형을 획득하게 된다. Adipose tissue is classified into white adipose tissue (WAT) and brown adipose tissue (BAT) according to its anatomical location, morphological structure, function and regulation. The process of differentiation of adipocytes is continuously converted from adipocytes to adipocytes throughout life. Differentiation from adipocytes to adipocytes shows distinct morphological and biochemical changes. Pre-established adipocytes or stromal progenitor cells derived from adipose tissue, such as 3T3-L1 cells, have been widely used to observe the process of adipocyte formation in vitro. Differentiation of adipocytes is induced by the combination of adipocyte derived complexes. By the treatment of the adipocyte-complexing cells, the cells begin to change shape, accompany some cell division, and acquire the phenotype of the adipocytes in 5-7 days.
녹차(Camellia sinensis L.)의 경우, 중국이나 일본에서 재배되는 소엽종은 자연 상태에서도 높이가 2?3m이고, 인도 아삼 지방의 대엽종은 높이가 15m에 달하므로 재배할 때에는 가지치기를 하여 높이가 0.5?1m 되도록 한다. 열매는 삭과이고 둥글며 모가 졌고 다음해 봄부터 자라기 시작하여 가을에 익기 때문에 꽃과 열매를 같은 시기에 볼 수 있다. 열매가 익으면 터져서 갈색의 단단한 종자가 나온다. 주요성분으로는 아피게닌, 아스트라갈린, 벤조알데하이드, 베타-카로텐, 베타-요논, 베타-시토스테롤 등 다양한 성분들과 칼슘, 철, 마그네슘, 망간, 인, 칼륨, 아연, 비타민 B1. B2. B3. B5, C를 함유하고 있으며, 항산화 효과, 항균 및 항암 효과가 알려져 있다(Food Sci. Biotechnol. Vol. 15, No.5, pp.672~676 (2006)).Green tea ( Camellia sinensis In case of L.), the leaflets grown in China or Japan are 2 ~ 3m high in natural condition, and the leaflets of Assam region of India are 15m high, so they should be pruned to 0.5 ~ 1m in height. . Fruits are capsules, round and gathered, and start to grow in the spring of next year and ripen in autumn, so you can see flowers and fruits at the same time. When the fruit ripens, it bursts, resulting in a hard brown seed. Main ingredients include apigenin, astragalin, benzoaldehyde, beta-carotene, beta-nonone, beta-sitosterol, and various ingredients such as calcium, iron, magnesium, manganese, phosphorus, potassium, zinc, and vitamin B1. B2. B3. It contains B5 and C, and is known to have antioxidant, antibacterial and anticancer effects (Food Sci. Biotechnol. Vol. 15, No. 5, pp. 672-676 (2006)).
블래더랙(Fucus vesiculosus L.)은 영국과 아일랜드의 해변가에 분포하며, 갈색 조류이다. 3년 정도 살며, 2m까지 자란다. 평평한 잎을 가지고 있으므로 구별하기 쉽고, 깊은 물속보다는 중간에서 자란다. 요오드와 점액질이 많다. 주요성분으로는 알루미늄, 바륨, 비스무스, 붕소, 칼슘, 크롬, 코발트, 구리, 갈륨, 요오드, 철, 리튬, 마그네슘, 망간, 니켈, 인, 칼륨, 실리콘, 은, 소디움, 스트론튬, 황, 주석, 티타늄, 바나디움, 비타민 A, 비타민 B-컴플렉스, 비타민 C, E, G, S, K, 아연, 지르코늄 등이 있다(Rita Berger, Hydrobiologia 514: 243-248, 2004.).Blacus rack ( Fucus vesiculosus L.) is a brown algae distributed on the beaches of England and Ireland. Lives about 3 years and grows up to 2m. It has a flat leaf, which makes it easy to distinguish and grows in the middle rather than in deep water. High in iodine and mucus Main ingredients include aluminum, barium, bismuth, boron, calcium, chromium, cobalt, copper, gallium, iodine, iron, lithium, magnesium, manganese, nickel, phosphorus, potassium, silicon, silver, sodium, strontium, sulfur, tin, Titanium, vanadium, vitamin A, vitamin B-complex, vitamins C, E, G, S, K, zinc, zirconium and the like (Rita Berger, Hydrobiologia 514: 243-248, 2004.).
차전초(Plantago asiatica L)는 질경이과의 다년초로 잡초같이 각처의 빈터에서 자라며 일본, 사할린, 오키나와, 타이완, 중국, 시베리아 동부와 말레이지아에 분포한다. 줄기가 없고 잎이 모두 나와서 비스듬히 퍼진다. 삭과는 꽃받침 길이의 2배 정도 되고 익으면 옆으로 갈라져서 뚜껑처럼 열리며 6 내지 8개의 검은 종자가 들어 있다. 약재인 차전자는 타원형이거나 불규칙한 긴 원형으로 약간 납작하고 길이는 약 2mm 정도이다. 표면은 황갈색이거나 흑갈색으로 가는 주름이 있고 한쪽 면에는 회백색의 조금 들어간 종제가 있으며 단단하다. 맛은 달고 성질은 차갑다. 다량의 점액질(약 9%)을 함유하고 그밖에 플란테놀 산(plantenolic acid), 호박산, 아데닌(adenine), 콜린(choline), 또 전초에서는 유큐빈(aucubin), 카탈폴(catalpol) 및 메틸카탈폴 (methylcatalpol)이 분리되었다. Plantago asiatica L is a perennial plant of the plantain family, and grows on the same vacant land as weeds and is distributed in Japan, Sakhalin, Okinawa, Taiwan, China, East Siberia and Malaysia. Stems are absent and leaves are spread out obliquely. A capsule is about twice as long as a calyx, and when ripened, it splits sideways, opens like a lid, and contains 6 to 8 black seeds. The medicinal herb is oval or irregularly long, slightly flat and about 2 mm long. The surface is yellowish brown or blackish brown with wrinkles, and on one side there is a little bit of grayish white seed material. The taste is sweet and the nature is cold. Contains large amounts of mucus (about 9%) and other plantenolic acid, succinic acid, adenine, choline, and in the outpost, aucubin, catalpol and methylcatalol (methylcatalpol) was isolated.
홍화(Carthamus tinctorius L.)는 국화과에 속하는 1년생 초본이며 동남아시아가 원산이었으나 인도, 극동, 북부 아프리카에서 재배되었다. 그 후 독일, 화란, 프랑스, 소련, 미국, 캐나다에 이어 지금은 미국과 멕시코가 주생산국이다. 종자는 희고 윤기가 있으며 짧은 관모가 있다. 두상화는 붉은빛이 도는 노란색, 엉겅퀴와 비슷하고 총포편은 잎 모양, 바늘 모양, 가시처럼 뾰족한 톱니가 있다. 주요성분으로는 유지(39?40%), 단백질(15%), 리놀레산(78%), 올레산(13%), 스테아르산(3%), 팔미트산(6%), 홍색색소 카르타민(Carthamin), 황색색소 사플로 옐로우(Safflor yellow), 사플로민(Safflomin), 루테올린-7-글루코사이드(Luteolin-7-glucoside, 잎), 리놀레산(Linoleic acid, 50?70%, 종자), 트라첼로사이드(Tracheloside), 마트시레시놀-4-O-β-글루코피라노사이드(Matciresinol-4-O-β-glucopyranoside)를 들 수 있다.Safflower ( Carthamus tinctorius L.) is a year-old herb belonging to the Asteraceae family, native to Southeast Asia, but cultivated in India, the Far East, and Northern Africa. Later, Germany, the Netherlands, France, the Soviet Union, the United States, and Canada, followed by the United States and Mexico. Seeds are white and glossy with short tubules. The head is similar to the reddish yellow and thistle, and the muzzle has the shape of leaves, needles, and thorns like thorns. Its main ingredients are fats and oils (39-40%), protein (15%), linoleic acid (78%), oleic acid (13%), stearic acid (3%), palmitic acid (6%), and red pigment cartamine ( Carthamin, Safflor yellow, Safflomin, Luteolin-7-glucoside (leaf), Linoleic acid (50-70%, seed), Tra Celloside (Tracheloside), Mathysirinol-4-O-β-glucopyranoside (Mtciresinol-4-O-β-glucopyranoside) is mentioned.
퀴노아(Chenopodium quinoa Willd.)는 쌀보다 조금 작은 둥근 모양으로 지난 수천년 동안 에콰도르, 페루, 볼리비아 등 안데스 지역에서 재배되고 있다. 주요성분으로는 단백질, 녹말, 비타민, 망간, 마그네슘, 철, 구리, 인 등의 무기질이 풍부하며, 이외에도 칼륨, 비타민-B1, 비타민-B3, 비타민-B6, 비타민-E 및 엽산도 들어 있다. 잉카제국이 강력했던 시절 군인들을 먹여 살리던 곡물이다. 남미의 안데스 산록에서 생산되는 일종의 생약(herb)의 열매로서, 남미 원주민들은 상처 치료를 위하여 이를 찧어서 상처에 바르기도 하였다.
Quinopodium quinoa Willd. Is slightly smaller than rice, and has been cultivated in the Andes, Ecuador, Peru and Bolivia, for thousands of years. Its main ingredients are rich in minerals such as protein, starch, vitamins, manganese, magnesium, iron, copper, and phosphorus, as well as potassium, vitamin-B1, vitamin-B3, vitamin-B6, vitamin-E and folic acid. It was the grain that fed the soldiers when the Inca Empire was powerful. It is a kind of herb produced in the Andes of South America. Native Americans of South America have crushed and applied it to wounds for healing.
최근 피부 및 체내에 축적된 지방 성분을 분해하기 위한 다양한 성분들이 개발되고 있다. 특히 여성들은 피하지방이 남성보다 많고, 특히 팔, 다리에 현저한 분포를 보이므로 여성들 중에는 특정 신체부위의 지방감소를 원하는 경우가 많으며, 이를 위해 다양한 시도를 하고 있다. 그러나 무분별한 체중감량을 위해 운동, 식사조절 외에 상업적 비만 프로그램 및 약물 복용 등으로 경제적 손실이나 심각한 합병증을 유발하기도 한다. 따라서 중성지방을 효과적으로 제거함으로써 우수한 슬리밍 효과를 나타내면서도, 인체에 안전하게 적용할 수 있는 제제의 개발이 필요한 실정이다.
Recently, various components for decomposing fat components accumulated in skin and body have been developed. In particular, women have more subcutaneous fat than men, and especially the arms and legs have a significant distribution, so many women want to reduce fat in certain body parts. However, in order to reckless weight loss, in addition to exercise and diet, commercial obesity programs and medications can cause economic loss or serious complications. Therefore, it is necessary to develop a formulation that can be safely applied to the human body while showing excellent slimming effect by effectively removing triglycerides.
본 발명은 녹차(Camellia sinensis L.)씨, 블래더랙(Fucus vesiculosus L.), 차전초(Plantago asiatica L), 홍화(Carthamus tinctorius L.) 및 퀴노아(Chenopodium quinoa Willd.)를 포함하는 화장료 조성물에 관한 것으로서, 상기 화장료 조성물은 지방세포 내 중성지방(triglyceride) 생성을 억제시킴으로써 우수한 슬리밍 효과를 나타낸다.
The present invention is a green tea ( Camellia sinensis L.) seeds, bladder rack ( Fucus vesiculosus L.), Plantago asiatica L), safflower ( Carthamus tinctorius L.) and quinoa ( Chenopodium quinoa Willd.) Relates to a cosmetic composition, the cosmetic composition exhibits an excellent slimming effect by inhibiting triglyceride production in adipocytes.
본 발명의 녹차씨, 블래더랙, 차전초, 홍화 및 퀴노아로부터 추출된 추출물은 지방세포 내 중성지방(triglyceride) 생성을 현저히 억제하여 우수한 슬리밍 효과를 나타내며, 피부 도포 시험에서도 뛰어난 탄력 증강 효과를 나타낸다.
The extract extracted from green tea seed, bladder rack, chajeoncho, safflower and quinoa of the present invention significantly inhibits triglyceride production in adipocytes and shows excellent slimming effect, and also shows excellent elasticity enhancing effect in skin application test.
본 발명은 녹차(Camellia sinensis L.)씨, 블래더랙(Fucus vesiculosus L.), 차전초(Plantago asiatica L), 홍화(Carthamus tinctorius L.) 및 퀴노아(Chenopodium quinoa Willd.)를 포함하는 화장료 조성물을 제공한다.The present invention is a green tea ( Camellia sinensis L.) seeds, bladder rack ( Fucus vesiculosus L.), Plantago asiatica L), safflower ( Carthamus tinctorius L.) and quinoa ( Chenopodium quinoa Willd.) Provides a cosmetic composition.
본 발명의 각 생약은 개개의 동속 식물로부터 유래된 생약들을 모두 포함한다.Each herb of the present invention includes all herb derived from the same plant.
특정 실시양태에서, 본 발명의 화장료 조성물 중의 각 추출물, 즉 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아 추출물의 조성비는 구체적으로 1 : 1~10 : 1~10 : 1~10 : 1~10, 보다 구체적으로 약 1 : 1~5 : 1~5 : 1~5 : 1~5, 보다 더 구체적으로 1 : 1~2 : 1~2 : 1~2 : 1~2 이나, 이로 한정되지 않는다.In a specific embodiment, the composition ratio of each extract in the cosmetic composition of the present invention, namely green tea seed, bladder rack, chajeoncho, safflower, quinoa extract, is specifically 1: 1-10: 1-10: 1-10: 1-10 More specifically, about 1: 1: 5: 1 ~ 5: 1 ~ 5: 1 ~ 5, and more specifically 1: 1: 2: 1 ~ 2: 1 ~ 2: 1 ~ 2, but are not limited thereto. .
특정 실시양태에서, 본 발명의 화장료 조성물 중에 포함되는 추출물은 물, 에탄올, 메탄올, 프로판올, 부탄올과 같은 C1 내지 C4의 저급알콜, 아세톤, 에틸아세테이트, 헥산, 에틸렌글리콜, 함수에틸렌글리콜, 부틸렌글리콜, 함수부틸렌글리콜, 프로필렌글리콜, 함수프로필렌글리콜, 글리세린, 함수글리세린 또는 이들 중 선택된 2종 이상의 혼합용매를 사용하여 추출된 것임을 특징으로 한다. In certain embodiments, the extracts comprised in the cosmetic composition of the present invention are C 1 to C 4 lower alcohols such as water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, ethylene glycol, ethylene glycol, butyl It is characterized in that it is extracted using len glycol, hydrous butylene glycol, propylene glycol, hydrous propylene glycol, glycerin, hydrous glycerin or two or more mixed solvents selected from them.
특정 실시양태에서, 본 발명의 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아 추출물은 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아를 모두 건조시킨 후, 원료 부피의 약 1~20배, 구체적으로 약 10~15배의 물, 저급 알콜 또는 이들의 약 1:0.1~1:10, 구체적으로 1:1~1:3의 혼합비를 갖는 혼합용매로 1~60℃, 구체적으로는 1~40℃ 온도에서 약 1일~30일, 구체적으로 약 1일~15일 정도에서 침적시키거나, 10~100℃, 구체적으로 40~100℃ 추출 온도에서 약 30분~2일, 구체적으로 약 1시간~1일 정도에서 초음파 추출, 환류추출 등의 추출방법에 의하여 수득할 수 있다. In certain embodiments, the green tea seed, bladder lag, chajeoncho, safflower, and quinoa extracts are dried after all of the green tea seed, bladder rack, chajeoncho, safflower, quinoa, and about 1-20 times the raw material volume, specifically, About 10 to 15 times of water, lower alcohol or a mixed solvent having a mixing ratio of about 1: 0.1 to 1:10, specifically 1: 1 to 1: 3, 1 to 60 ° C, specifically 1 to 40 It is deposited at about 1 to 30 days at about ℃ temperature, specifically about 1 to 15 days, or about 30 minutes to 2 days at an extraction temperature of 10 ~ 100 ℃, specifically 40 ~ 100 ℃, specifically about 1 hour It can be obtained by the extraction method such as ultrasonic extraction, reflux extraction in ~ 1 day.
상기 추출물은 조성물 총 중량에 대하여 상기 추출물을 0.001 내지 10 % 중량 백분율, 바람직하게는 0.1 내지 8 % 중량 백분율, 가장 바람직하게는 0.5 내지 5 % 중량 백분율로 포함하나, 피부 유분 정도에 따라서 적절히 선택하는 것이 더욱 바람직하다.The extract comprises 0.001 to 10% by weight, preferably 0.1 to 8% by weight, most preferably 0.5 to 5% by weight, based on the total amount of skin oil, based on the total skin composition. More preferred.
상기 추출방법에 의해 얻어진 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아 추출물의 지방세포 내 중성지방(triglyceride) 생성을 억제 효과를 확인해 본 결과 슬리밍 화장료 조성물로 사용될 수 있음을 확인하였다.Green tea seed, bladder rack, chajeoncho, safflower, quinoa extract obtained by the extraction method confirmed the effect of inhibiting the triglyceride production in fat cells (triglyceride) confirmed that it can be used as a slimming cosmetic composition.
또한, 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 또, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 총중량에 대하여 바람직하게는 0.01 - 5 % 중량 백분율, 보다 바람직하게는 0.01 - 3 % 중량 백분율로 배합된다.In addition, any of the above-mentioned components may be blended within the range not to impair the objects and effects of the present invention, but it is preferably 0.01 to 5% by weight based on the total weight, More preferably from 0.01 to 3% by weight.
본 발명의 화장료는 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다.The cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture or the like.
본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.
Ingredients included in the cosmetic composition of the present invention may include components commonly used in cosmetic compositions in addition to the extract as an active ingredient, for example, conventional auxiliary agents such as stabilizers, solubilizers, vitamins, pigments and flavorings. And carriers.
이하 본 발명을 다음의 실시예, 실험예 및 제조예에 의해 설명하고자 한다. 그러나 이들은 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐 본 발명의 권리범위가 이들에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described by the following Examples, Experimental Examples and Preparation Examples. However, these are provided only to more easily understand the present invention, but the scope of the present invention is not limited thereto.
제조예Manufacturing example 1. 배합비에 따른 1. According to the compounding ratio 녹차씨Green tea seed , , 블래더랙Bladder Rack , , 차전초Chachocho , 홍화, , Safflower, 퀴노아Quinoa 혼합 추출물의 제조 Preparation of Mixed Extract
녹차씨, 블래더랙, 차전초, 홍화, 퀴노아를 하기 표 1의 비로 혼합하고, 70% 함수에탄올 (중량비로서 물 : 에탄올 = 3 : 7)을 원료의 10배 분량으로 넣고 추출기로 상온에서 5일간 침적 추출한 후 400 메쉬 여과포로 여과하고 0.45um 의 필터로 여과하여 냉각기가 달린 감압 농축기로 농축하여 비교예 1 내지 5, 실시예 1 내지 20을 제조하였다.
Green tea seeds, bladder racks, chajeoncho, safflower, quinoa are mixed in the ratio of the following Table 1, 70% hydrous ethanol (water by weight: ethanol = 3: 7) in 10 times the amount of the raw material and the extractor at room temperature for 5 days After immersion extraction, the filtrate was filtered through a 400 mesh filter cloth, filtered through a filter of 0.45 um, and concentrated in a vacuum condenser with a cooler to prepare Comparative Examples 1 to 5 and Examples 1 to 20.
(kg)Solvent amount used
(kg)
(g)Yield
(g)
제조예Manufacturing example 2. 추출용매별 2. Extraction solvent 녹차씨Green tea seed , , 블래더랙Bladder Rack , , 차전초Chachocho , 홍화, , Safflower, 퀴노아Quinoa 혼합 추출물의 제조 Preparation of Mixed Extract
실시예 11의 배합비에 따라, 녹차씨 20g, 블래더랙 40g, 차전초 40g, 홍화 20g, 퀴노아 20g 을 혼합하여, 하기 표 2의 각 용매 2.0kg에 넣고 추출기로 상온에서 5일간 추출한 후 400 메쉬 여과포로 여과하고 0.45um의 필터 여과하여 실시예 21 내지 25를 제조하여, 하기 실험의 시료로 사용하였다.
According to the blending ratio of Example 11, 20g green tea seed, bladder rack 40g, chajeoncho 40g, safflower 20g, quinoa 20g was mixed, put into 2.0kg of each solvent of Table 2 and extracted for 5 days at room temperature with an extractor 400 mesh filter cloth Example 21 to 25 were prepared by filtration with a filter of 0.45um, and used as a sample of the following experiment.
실험예Experimental Example 1. 지방세포 독성 측정 1. Measurement of fat cell toxicity
지방세포인 3T3-L1 세포를 10% 우태아혈청(bovine calf serum)이 들어있는 DMEM에서 세포배양하였다. 세포밀도가 약 85?90% 가량 될 때 비교예 1 내지 5 및 실시예 1 내지 25를 100ug/ml의 농도로 처리한 24시간 후 세포활성 정도를 측정하였다. 하기 표 3에서 보듯이 비교예 1 내지 5 및 실시예 1 내지 25를 지방세포주에 처리하였을 때, 세포독성이 없음을 관찰할 수 있었다.
Adipocytes, 3T3-L1 cells, were cultured in DMEM containing 10% bovine calf serum. When the cell density was about 85-90%, the degree of cell activity was measured after 24 hours of Comparative Examples 1 to 5 and Examples 1 to 25 at a concentration of 100 ug / ml. As shown in Table 3, when the Comparative Examples 1 to 5 and Examples 1 to 25 were treated with the adipocyte line, no cytotoxicity was observed.
실험예Experimental Example 2. 지방세포 내 중성지방( 2. Triglycerides in adipocytes triglyceridetriglyceride ) 생성 억제 효능 평가Evaluation of inhibitory effect on production
분화된 지방세포를 5×104 cells/well로 12-well 플레이트에서 24시간 배양시킨 후 HBSS로 한차례 세척하고 FBS를 넣지 않은 배지로 교환한 후, 비교예 1 내지 5 및 실시예 1 내지 25를 100ug/ml의 농도로 제조한 시료를 첨가하여 24시간 반응시켰다. 상기 세포를 PBS로 3회 세척한 후 추출완충액(extraction buffer)(20 mM Tris, 1 mM EDTA 및 1 mM 2-머캅토에탄올)으로 수확하였다. 모은 세포를 얼음 상에서 G26 니들로 6회 통과한 다음, 500×g, 4℃에서 3분간 원심분리하고 상층액 만을 취하여 실험에 사용하였다. 미국 시그마사(St. Louis, MO, U.S.A.)로부터 구입한 GPO-TRINDER kit를 사용하여 중성지방(triglyceride, TG)을 발색 반응시킨 후 540nm에서 ELISA reader로 흡광도를 측정하였다. 그 결과를 하기 표 4에 타내었다.
Differentiated adipocytes were incubated for 24 hours in 12-well plates at 5 × 10 4 cells / well, washed once with HBSS and exchanged with medium without FBS, followed by Comparative Examples 1-5 and Examples 1-25. Samples prepared at a concentration of 100 ug / ml were added and reacted for 24 hours. The cells were washed three times with PBS and then harvested with extraction buffer (20 mM Tris, 1 mM EDTA and 1 mM 2-mercaptoethanol). The collected cells were passed six times with G26 needles on ice, then centrifuged at 500 × g, 4 ° C. for 3 minutes, and only the supernatant was taken and used for the experiment. The triglyceride (TG) was developed using a GPO-TRINDER kit purchased from Sigma (St. Louis, MO, USA), and the absorbance was measured at 540 nm with an ELISA reader. The results are shown in Table 4 below.
표 4에 나타난 바와 같이, 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아 혼합 추출물을 1:2:2:1:1로 혼합하여 추출한 추출물이 대조군에 비하여 중성지방의 농도가 현저하게 감소되었다.
As shown in Table 4, the extract of the green tea seed, bladder rack, chajeoncho, safflower, and quinoa mixed extract 1: 2: 2: 1: 1 was significantly reduced in the concentration of triglycerides compared to the control.
제조예Manufacturing example 3. 스킨로션의 제조 3. Preparation of Skin Lotion
3-1. 제조(1)3-1. Manufacture (1)
표 5의 11번에 2, 3, 4 및 8번을 순서대로 투입하여 교반하고 용해시킨 후, 5번을 60℃정도 가열하여 용해시킨 후 10번을 투입하여 교반한 후 11번에 투입하였다. 마지막으로 1, 6, 7 및 9번을 투입하여 충분히 교반한 뒤 마이크로플루다이저를 통과시킨 후 숙성시켰다. 원료 1의 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아 혼합 추출물은 상기 실시예 25의 추출물을 시료로 사용하였다.
2, 3, 4, and 8 were added to 11 in Table 5 in order, followed by stirring and dissolving. Then, 5 was heated to 60 ° C. for dissolution and 10 times were added thereto, followed by stirring. Finally, 1, 6, 7 and 9 were added and stirred sufficiently, and then passed through a microfluidizer and aged. Green tea seed, bladder rack, chajeoncho, safflower, quinoa mixed extract of the raw material 1 used the extract of Example 25 as a sample.
3-2. 비교제조(1)3-2. Comparative Manufacturing (1)
실시예 25와 같은 제조방법으로 표 5의 1번 원료만 제외하고 스킨로션을 제조하였다.
A skin lotion was prepared except for the first raw material of Table 5 in the same manufacturing method as in Example 25.
제조예Manufacturing example 4. 영양로션의 제조 4. Preparation of Nutritional Lotion
4-1.제조(2)4-1.Manufacturing (2)
표 6의 원료물질 2, 3, 4, 5 및 6을 일정한 온도에서 균질화한 것(이하, "비이온계 양친매성 지질"이라 한다)과 원료물질 1, 7, 8 및 14를 혼합하고 일정한 온도에서 균질화하여 마이크로플루다이저를 통과시키고, 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 마이크로플루다이저에 재차 통과시켰다. 그 후, 10, 11, 12 및 13을 투입하여 분산시켜 안정화하고 숙성시켰다. 상기 실시예 25의 추출물을 시료로 사용하였다.
The raw materials 2, 3, 4, 5 and 6 of Table 6 were homogenized at a constant temperature (hereinafter referred to as "nonionic amphiphilic lipids") and the raw materials 1, 7, 8 and 14 were mixed, and then Homogenized at and passed through the microfluidizer, and then the raw material 9 was slowly added and homogenized at a constant temperature, and then passed through the microfluidizer again. Thereafter, 10, 11, 12 and 13 were added to disperse to stabilize and mature. The extract of Example 25 was used as a sample.
4-2. 비교제조(2)4-2. Comparative Manufacturing (2)
제조예 3-1과 같은 제조방법으로 표 6의 1번 원료만 제외하고 영양로션을 제조하였다.
Nutritional lotion was prepared by the same preparation method as Preparation Example 3-1, except for ingredient No. 1 in Table 6.
제조예Manufacturing example 4. 영양크림의 제조 4. Preparation of Nutritional Cream
4-1. 제조 (3)4-1. Manufacture (3)
표 7의 원료물질 2, 3, 4, 5 및 6을 일정한 온도에서 균질화한 것(이하, "비이온계 양친매성 지질"이라 한다)과 원료물질 1, 7, 8 및 14를 혼합하고 일정한 온도에서 균질화하여 마이크로플루다이저를 통과시키고, 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 마이크로플루다이저에 재차 통과시켰다. 그 후, 10, 11, 12 및 13을 투입하여 분산시켜 안정화하고 숙성시켰다.
The raw materials 2, 3, 4, 5 and 6 of Table 7 were homogenized at a constant temperature (hereinafter referred to as "nonionic amphiphilic lipids"), and the raw materials 1, 7, 8 and 14 were mixed and fixed at a constant temperature. Homogenized at and passed through a microfluidizer, and the raw material 9 was gradually added at a constant temperature to homogenize, and then passed through the microfluidizer again. Thereafter, 10, 11, 12 and 13 were added to disperse to stabilize and mature.
4-2. 비교제조(3)4-2. Comparative Manufacturing (3)
제조예 4-1과 같은 제조방법으로 표 7의 1번 원료만 제외하고 영양크림을 제조하였다.
Nutritional creams were prepared except for the first raw material of Table 7 according to the same method as in Preparation Example 4-1.
실험예Experimental Example 4. 피부탄력 효과 측정 시험 4. Skin elasticity effect measurement test
제조예 3의 제조(1)과 비교제조(1)의 크림을 피부에 30일간 매일 두 차례 도포하여 피부탄력효과를 측정하였다. 큐토미터 샘-474를 사용하여, 시료 적용 전의 피부 탄력도를 측정하고, 각각의 시료 25㎖/㎠를 상완부에 도포하였다. 도포 후 10일, 20일, 30일 경과후의 피부탄력도를 측정하였다. 온도 20℃, 습도 50%로 조절되는 항온, 항습실에서 실시하였다. 피시험자는 20대~30대 남녀, 20명을 대상으로 시행하였다.
The skin elasticity effect was measured by applying the cream of Preparation (1) and Comparative Preparation (1) of Preparation Example 3 to the skin twice daily for 30 days. The skin elasticity before sample application was measured using the cutometer SAM-474, and 25 mL / cm <2> of each sample was apply | coated to the upper arm part. Skin elasticity after 10 days, 20 days, and 30 days after application was measured. It was carried out in a constant temperature, constant humidity room controlled to a temperature of 20 ℃, 50% humidity. The test subjects were 20 males and 20s.
표 8의 실험결과 알 수 있는 바와 같이 녹차씨, 블래더랙, 차전초, 홍화, 퀴노아 추출물을 포함한 제조(1)의 피부탄력이 비교제조(1)에 비해 탁월한 효과가 있는 것을 확인할 수 있었으며, 실험대상자 중 특이할만한 이상 반응을 나타낸 대상은 없었다.As can be seen from the results of Table 8, it was confirmed that the skin elasticity of the preparation (1) including green tea seed, bladder rack, chajeoncho, safflower, and quinoa extract was superior to that of the comparative preparation (1). None of the subjects showed unusual adverse reactions.
Claims (17)
Green tea (Camellia sinensis L.) seeds, bladder deoraek (Fucus vesiculosus L.), Plantago asiatica L), safflower ( Carthamus tinctorius L.) and Quinoa ( Chenopodium quinoa Willd.) A cosmetic composition comprising an extract extracted from the active ingredient.
According to claim 1, wherein the composition ratio of the extract extracted from green tea seed, bladder rack, chajeoncho, safflower and quinoa is 1: 1 to 10: 1 to 10: 1 to 10: 1 to 10: 1 to 10 Cosmetic composition.
According to claim 1, wherein the composition ratio of the extract extracted from green tea seed, bladder rack, chajeoncho, safflower and quinoa is 1: 1 to 5: 1 to 5: 1 to 5: 1 to 5: 1 to 5. Cosmetic composition.
According to claim 1, wherein the composition ratio of the extract extracted from green tea seeds, bladder racks, chajeoncho, safflower and quinoa is characterized in that 1: 1 to 2: 1 to 2: 1 to 2: 1 to 2: 1 to 2. Cosmetic composition.
The cosmetic composition according to claim 1, wherein the composition ratio of the extract extracted from green tea seed, bladder rack, chajeoncho, safflower and quinoa is 1: 2: 2: 1: 1.
The method of claim 1, wherein the extract is water, C 1 -4 lower alcohols, acetone, ethyl acetate, hexane, ethylene glycol, function glycol, butylene glycol, function-butylene glycol, propylene glycol, and containing propylene glycol, glycerin, and Cosmetic composition, characterized in that extracted using one solvent or two or more mixed solvents selected from the group consisting of hydrous glycerin.
The method of claim 1, wherein the extract is a water and a C 1 -4 lower alcohol 1: A cosmetic composition characterized in that the extraction with a solvent mixture mixed at a ratio of 0.1 to 10.
The method of claim 1, wherein the extract is a water and a C 1 -4 lower alcohol 1: A cosmetic composition characterized in that the extraction with a solvent mixture mixed at a ratio of 1 to 3.
The cosmetic composition according to claim 1, comprising 0.001 to 10% by weight of the extract based on the total weight of the cosmetic composition.
The cosmetic composition according to claim 1, comprising 0.1 to 8% by weight of the extract based on the total weight of the cosmetic composition.
The cosmetic composition according to claim 1, comprising 0.5 to 5% by weight of the extract based on the total weight of the cosmetic composition.
Slimming cosmetic comprising the cosmetic composition of any one of claims 1 to 11 as an active ingredient.
A cosmetic for enhancing skin elasticity, comprising the cosmetic composition of any one of claims 1 to 11 as an active ingredient.
1 내지 60℃의 온도 조건 하에 침적시키거나; 또는
10 내지 100℃의 온도 조건 하에 추출하는 것을 특징으로 하는 화장료 조성물의 제조방법.
Add green tea seed, bladder rack, chajeoncho, safflower and quinoa dry samples to 1-20 times the total weight of the extraction solvent,
To be deposited under temperature conditions of 1 to 60 ° C; or
Method for producing a cosmetic composition, characterized in that the extraction under the temperature conditions of 10 to 100 ℃.
15. The method of claim 14 wherein the extraction solvent from water, C 1 -4 lower alcohols, acetone, ethyl acetate, hexane, butylene glycol, function-butylene glycol, propylene glycol, and containing propylene glycol, glycerin and the function groups of glycerol Method of producing a cosmetic composition, characterized in that the selected solvent or two or more mixed solvents.
15. The method of claim 14 wherein the extraction solvent is water and the lower alcohol C 1 -4 1: Preparation of a cosmetic composition, characterized in that a mixed solvent were mixed in a ratio of from 0.1 to 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110007653A KR20120086436A (en) | 2011-01-26 | 2011-01-26 | Cosmetic composition for slimming |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110007653A KR20120086436A (en) | 2011-01-26 | 2011-01-26 | Cosmetic composition for slimming |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20120086436A true KR20120086436A (en) | 2012-08-03 |
Family
ID=46872237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020110007653A Ceased KR20120086436A (en) | 2011-01-26 | 2011-01-26 | Cosmetic composition for slimming |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20120086436A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170224611A1 (en) * | 2012-11-15 | 2017-08-10 | Basf Corporation | Cosmetic Compositions Comprising Marine Plants |
| KR102027827B1 (en) * | 2019-04-29 | 2019-10-02 | 임재선 | Composition comprising lemon balm extract for lipolysis |
| WO2020197041A1 (en) * | 2019-03-25 | 2020-10-01 | 임재선 | Injectable and cosmetic compositions comprising lemon balm extract as active ingredient |
-
2011
- 2011-01-26 KR KR1020110007653A patent/KR20120086436A/en not_active Ceased
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170224611A1 (en) * | 2012-11-15 | 2017-08-10 | Basf Corporation | Cosmetic Compositions Comprising Marine Plants |
| WO2020197041A1 (en) * | 2019-03-25 | 2020-10-01 | 임재선 | Injectable and cosmetic compositions comprising lemon balm extract as active ingredient |
| JP2020158484A (en) * | 2019-03-25 | 2020-10-01 | 林 載▲そん▼LIM, Jae Sun | Injection agent and cosmetic composition containing lemon balm extract as active ingredient |
| CN111728903A (en) * | 2019-03-25 | 2020-10-02 | 林载钐 | Injection and cosmetic composition containing lemon balm extract as active ingredient |
| CN111728903B (en) * | 2019-03-25 | 2022-11-01 | 林载钐 | Injection and cosmetic composition containing lemon balm extract as active ingredient |
| KR102027827B1 (en) * | 2019-04-29 | 2019-10-02 | 임재선 | Composition comprising lemon balm extract for lipolysis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101544532B1 (en) | Composition comprising an extract of Cynanchi wilfordii for preventing or treating of climacteric disorder | |
| KR101758998B1 (en) | Composition for preventing hair loss and improving hair growth comprising plant extract | |
| Sandeep et al. | Moringa for nutritional security (Moringa oleifera Lam.) | |
| KR100687468B1 (en) | Cosmetic composition containing sprout vegetable fermented extract having immune enhancing and moisturizing effect | |
| KR101626437B1 (en) | Cosmetic composition for improving skin inflammation or reducing skin irritation | |
| KR101794006B1 (en) | Anti inflammatory comprising plant extract | |
| KR102004366B1 (en) | A cosmetic composition comprising centipeda minima extract | |
| KR101829891B1 (en) | A cosmetic composition comprising osmanthus asiaticus extract and clematis apiifolia extract | |
| KR20120086436A (en) | Cosmetic composition for slimming | |
| KR101473940B1 (en) | Hair cosmetic composition for preventing hair loss and improving the scalp comprising the complex extracts of Swertia japonica MAKINO, Paeonia lactiflora, quisetum arvense L. and peach | |
| KR101517833B1 (en) | A composotion for the treatment of dyslipidemia comprising the red ginseng complex | |
| KR101980887B1 (en) | A cosmetic composition comprising trichosanthes kirilowii extract and metaplexis japonica extract | |
| KR20120137907A (en) | A composition of cosmetics comprising sambung nyawa extract | |
| JP5597642B2 (en) | Antioxidant cosmetic composition containing smoked and processed sweet chrysanthemum and cinnamon extracts | |
| KR101070469B1 (en) | Composition effective for alleviating atopic dermatitis | |
| KR20160003914A (en) | Cosmetic composition for anti-inflammation or improving skin trouble containing herb extracts | |
| KR20160003920A (en) | Cosmetic composition for anti-inflammation or improving skin trouble containing herb extracts | |
| KR100747415B1 (en) | Cosmetic composition containing extract mixture having effect of alleviating female breast | |
| KR102273428B1 (en) | An anti-obesity composition comprising a black ginger extract as a main component and a process for producing the same | |
| KR101835661B1 (en) | A cosmetic composition containing ceriporia lacerata extract for alleviating skinitching and preventing dermatitis and cosmetics container including the same | |
| KR101682458B1 (en) | Cosmetic composition for slimming | |
| KR101998685B1 (en) | A cosmetic composition comprising arenaria serpyllifolia extract | |
| KR101596576B1 (en) | Cosmetic composition and a method of manufacturing | |
| KR101684869B1 (en) | Bath agent containing ceriporia lacerata extract | |
| KR20160013534A (en) | A cosmetic composition comprising of Sorbus commixta Hedl extract for slimming |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| D14-X000 | Search report completed |
St.27 status event code: A-1-2-D10-D14-srh-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |